Articles on this page are updated by ProfileData Research on an hourly basis. To see the summary of the SENS notice, please click on the headline. To read the original SENS message, please click on the link in the summary.



Date Headline/Title
24 December 20142014 Anti-Retroviral Tender Results
10 December 2014Results of AGM
10 December 2014Changes to the Board
05 December 2014Directors Dealings
11 November 2014Clarification in Respect of Form of Proxy
31 October 2014Aspen Holdings Acquires Stake In Infant Milk Formula Production Facility In New Zealand
30 October 2014No change statement and notice of annual general meeting
23 October 2014Dealings in securities by directors company secretary and directors of a major subsidiary
20 October 2014Aspen to acquire license rights
09 October 2014Aspen to enter strategic collaboration with GlaxoSmithKline in Japan
26 September 2014Further announcement regarding the disposal of rights to commercialise fondaparinux products in the US
10 September 2014Aspen final results 30 June 2014
08 September 2014Year-end Results and Results Presentation
03 September 2014Pre-Closed Period Conference Call
29 August 2014Trading Statement
30 June 2014Appointment of Maureen Manyama-Matome as member of the Audit & Risk Committee
30 June 2014Response to media reports following pre-closed period conference call
27 June 2014Dealings by a Director of a Major Subsidiary
04 June 2014Dealings by a Director of a Major Subsidiary
20 May 2014Directors Dealings
19 May 2014Appointment of an Independent Non-Executive Director
31 March 2014Dealing in securities by a director of a major subsidiary
24 March 2014Directors Dealings
19 March 2014Dealing in securities by a director of a major subsidiary
06 March 2014Aspen interim result December 2013
21 February 2014Voluntary Trading Statement
Powered by ProfileData